Abstract
We described a novel synthetic peptide in which a glutamine residue binds through hydrogen bonding to a guanine-base and a trytophan residue intercalates with K+ resulting in stabilization of a human telomeric G-quadruplex with high selectivity over its complementary c-rich strand and a double-stranded DNA and its complementary C-rich strand. This peptide offers great potential for cancer treatment by inhibiting the telomere extension by telomerase.
Original language | English |
---|---|
Pages (from-to) | 40255-40262 |
Number of pages | 8 |
Journal | RSC Advances |
Volume | 9 |
Issue number | 69 |
DOIs | |
Publication status | Published - 2019 |